Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bionano Genomics, Inc. (BNGO : NSDQ)
 
 • Company Description   
BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San Diego, United States.

Number of Employees: 299

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.67 Daily Weekly Monthly
20 Day Moving Average: 7,105,667 shares
Shares Outstanding: 289.70 (millions)
Market Capitalization: $483.79 (millions)
Beta: 2.15
52 Week High: $9.12
52 Week Low: $1.16
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -3.47% 5.70%
12 Week -20.48% -10.63%
Year To Date -44.15% -31.77%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
9540 TOWNE CENTRE DRIVE SUITE 100
-
SAN DIEGO,CA 92121
USA		 ph: 858-888-7600
fax: -		 arr@lifesciadvisors.com http://www.bionanogenomics.com
 
 • General Corporate Information   
Officers
R. Erik Holmlin - Chief Executive Officer and Director
Christopher Stewart - Chief Financial Officer
David L. Barker - Director
Albert A. Luderer - Director
Yvonne Linney - Director

Peer Information
Bionano Genomics, Inc. (CORR.)
Bionano Genomics, Inc. (RSPI)
Bionano Genomics, Inc. (CGXP)
Bionano Genomics, Inc. (BGEN)
Bionano Genomics, Inc. (GTBP)
Bionano Genomics, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 09075F107
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 289.70
Most Recent Split Date: (:1)
Beta: 2.15
Market Capitalization: $483.79 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.10 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.37 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.55
Price/Cash Flow: -
Price / Sales: 23.59
EPS Growth
vs. Year Ago Period: -120.00%
vs. Previous Quarter: -37.50%
Sales Growth
vs. Year Ago Period: 79.80%
vs. Previous Quarter: -9.62%
ROE
03/31/22 - -27.06
12/31/21 - -20.80
09/30/21 - -22.45
ROA
03/31/22 - -25.07
12/31/21 - -19.52
09/30/21 - -20.97
Current Ratio
03/31/22 - 12.99
12/31/21 - 12.47
09/30/21 - 19.32
Quick Ratio
03/31/22 - 12.12
12/31/21 - 11.91
09/30/21 - 18.81
Operating Margin
03/31/22 - -440.61
12/31/21 - -401.17
09/30/21 - -388.76
Net Margin
03/31/22 - -450.73
12/31/21 - -402.84
09/30/21 - -390.68
Pre-Tax Margin
03/31/22 - -478.59
12/31/21 - -434.64
09/30/21 - -390.43
Book Value
03/31/22 - 1.07
12/31/21 - 1.17
09/30/21 - 1.22
Inventory Turnover
03/31/22 - 1.58
12/31/21 - 1.92
09/30/21 - 2.14
Debt-to-Equity
03/31/22 - 0.01
12/31/21 - 0.01
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 1.16
12/31/21 - 1.07
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©